Nikolay V. Manyakov is a Senior Director in the Data Science and Digital Health organization at Johnson & Johnson's Innovative Medicine Research and Development, based in Beerse, Belgium. He holds a PhD in Computer Science, a PhD in Biomedical Sciences, and an MSc in Mathematics. Before joining Johnson & Johnson in 2013, he held various academic roles, focusing on machine learning, data science, and biosignal processing. At Johnson & Johnson, he played a key role in pioneering digital phenotyping research. In his current position, he leads a team responsible for overseeing analytics related to digital biomarkers and endpoints across the company's entire portfolio.
